Editor-in-Chief Mark Giembycz
Snyder Institute for Chronic Diseases
University of Calgary
2500 University Dr. NW, Calgary
Alberta, Canada T2N 1N4
Editorial Board J. D. Brain –
Harvard School of Public Health, USA L. Cameron –
Schulich Medicine & Dentistry, London, Ontario, Canada B. Canning –
Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland, USA E. D. Crandall –
Keck School of Medicine, USA L. Donnelly –
Imperial College London, UK W. Jungraithmeyr –
Brandenburg Medical School, Neuruppin, Germany D. Knight –
University of Newcastle, Australia W. L. Lee –
University of Toronto, Canada M. Lindsay –
University of Bath, UK L. Murray –
MedImmune Ltd, Cambridge, UK R. Newton –
University of Calgary, Canada M.W. Perkins –
US Army Medical Research Institute of Chemical Defense, MD, USA I. Rahman –
University of Rochester, USA V. Rehan –
David Geffen School of Medicine at UCLA, USA S. I. Rennard –
University of Nebraska Medical Center, USA P. Sriramarao –
University of Minnesota,USA